Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata

被引：7

作者：

Chen, Dandan ^{[1
]}

Huang, Wenhan ^{[1
]}

Wang Zhongjie ^{[1
]}

Ren Feifeng ^{[1
]}

Luo, Lei ^{[1
]}

Jun, Zhou ^{[1
]}

Huang Dongmei ^{[1
]}

Tian, Mengxue ^{[1
]}

Tang, Lin ^{[1
]}

机构：

[1] Chongqing Med Univ, Affiliated Hosp 2, Dept Rheumatol & Immunol, Chongqing 400010, Peoples R China

来源：

RHEUMATOLOGY | 2022年 / 61卷 / 08期

基金：

中国国家自然科学基金;

关键词：

DISEASE-ACTIVITY; INTERFERON;

D O I：

10.1093/rheumatology/keac084

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：E221 / E223

页数：3

共 9 条

[1] The role of interferons type I, II and III in myositis: A review [J].

Bolko, Lois ;

Jiang, Wei ;

Tawara, Nozomu ;

Landon-Cardinal, Oceane ;

Anquetil, Celine ;

Benveniste, Olivier ;

Allenbach, Yves .

BRAIN PATHOLOGY, 2021, 31 (03)

[2] Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease [J].

Chen, Zhiwei ;

Wang, Xiaodong ;

Ye, Shuang .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (03) :291-293

[3] JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases [J].

de Medeiros, Ana Karina Alves ;

Speeckaert, Reinhart ;

Desmet, Eline ;

Van Gele, Mireille ;

De Schepper, Sofie ;

Lambert, Jo .

PLOS ONE, 2016, 11 (10)

[4] Relationship between disease activity and type 1 interferon-and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis [J].

Greenberg, S. A. ;

Higgs, B. W. ;

Morehouse, C. ;

Walsh, R. J. ;

Kong, S. Won ;

Brohawn, P. ;

Zhu, W. ;

Amato, A. ;

Salajegheh, M. ;

White, B. ;

Kiener, P. A. ;

Jallal, B. ;

Yao, Y. .

GENES AND IMMUNITY, 2012, 13 (03) :207-213

[5] Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon in dermatomyositis [J].

Huard, C. ;

Gulla, S. V. ;

Bennett, D. V. ;

Coyle, A. J. ;

Vleugels, R. A. ;

Greenberg, S. A. .

BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (05) :1224-1230

[6]

Illa I, 1997, AM J PATHOL, V151, P81

[7] Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib [J].

Jabbari, Ali ;

Dai, Zhenpeng ;

Xing, Luzhou ;

Cerise, Jane E. ;

Ramot, Yuval ;

Berkun, Yackov ;

Sanchez, Gina A. Montealegre ;

Goldbach-Mansky, Raphaela ;

Christiano, Angela M. ;

Clynes, Raphael ;

Zlotogorski, Abraham .

EBIOMEDICINE, 2015, 2 (04) :351-355

[8] Alopecia areata investigational assessment guidelines - Part II [J].

Olsen, EA ;

Hordinsky, MK ;

Price, VH ;

Roberts, JL ;

Shapiro, J ;

Canfield, D ;

Duvic, M ;

King, LE ;

McMichael, AJ ;

Randall, VA ;

Turner, ML ;

Sperling, L ;

Whiting, DA ;

Norris, D .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (03) :440-447

[9] New and Emerging Therapies for Alopecia Areata [J].

Pourang, Aunna ;

Mesinkovska, Natasha Atanaskova .

DRUGS, 2020, 80 (07) :635-646

← 1 →